SCHEMBL19259501

SCHEMBL19259501

O=C(O)Nn1c2ccccc2c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.50
KDM4E B2RXH2 4/20 0.48
FABP4 P15090 4/20 0.47
FABP5 Q01469 4/20 0.47
POLB P06746 1/20 0.47
FABP3 P05413 2/20 0.46
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
HDAC6 Q9UBN7 1/20 0.42
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSPO P30536 1/20 0.40
P2RX4 Q99571 1/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28504871 0.82 CYP3A4 (0.59) SLC6A2KDM4ELMNAHTTHDAC6
SCHEMBL31241488 0.81 POLB (0.55) SLC6A2KDM4EFABP4FABP5POLB
SCHEMBL8836561 0.80 ALDH1A1 (0.42) SLC6A2KDM4EFABP4FABP5POLB
SCHEMBL30766244 0.77 LIPE (0.47) SLC6A2KDM4EALDH1A1LMNAMAPT
SCHEMBL19272150 0.77 LIPE (0.47) SLC6A2KDM4EALDH1A1LMNAMAPT
SCHEMBL28754715 0.75 POLB (0.48) SLC6A2KDM4EFABP4FABP5POLB
SCHEMBL19272298 0.75 KDM4E (0.42) SLC6A2KDM4EFABP4FABP5POLB
SCHEMBL31241484 0.74 CYP3A4 (0.54) KDM4EPOLBALDH1A1LMNAMAPT
SCHEMBL31241487 0.74 CYP3A4 (0.54) KDM4EPOLBALDH1A1LMNAMAPT
SCHEMBL31241486 0.74 CYP3A4 (0.54) KDM4EPOLBALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858922-B2 Sulfonylureas and related compounds and use of same THE UNIVERSITY OF QUEENSLAND (AU) 2024-01-02 US disclosed
US-20200299284-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME INFLAZOME LIMITED (IE) 2020-09-24 US disclosed
EP-3416948-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME The University Of Queensland (AU) 2018-12-26 EP disclosed
WO-2017140778-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME THE UNIVERSITY OF QUEENSLAND (AU) 2017-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11858922-B2 Sulfonylureas and related compounds and use of same NLRP3, NOD1, PYCARD SLC6A2 2259/4885KDM4E 2827/4885FABP4 1843/4885
US-20200299284-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME NLRP3, NOD1, PYCARD SLC6A2 2259/4885KDM4E 2827/4885FABP4 1843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.